当前位置：首页 > 文献互助 > 互助详情

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy复制

用户mZF4owCu6Hq0 2小时前 13 20 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-03-30 17:32:21 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.ccell.2025.05.006复制

文献链接: https://doi.org/10.1016/j.ccell.2025.05.006复制

其他信息:

上一篇：Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions

下一篇：RNA interference with zilebesiran for mild to moderate hypertension: the KARDIA-1 randomized clinical trial

互助时间线

2026-03-23 17:35:33 [完结求助]

楼主确认了用户L5Szh7KYEXDR应助的文件是正确的, 求助状态变成 已完结

2026-03-23 17:32:21 [上传文件]

用户L5Szh7KYEXDR上传了文件(pdf 12.03 MB), 求助状态变成 待确认

2026-03-23 17:31:38 [发起求助]

最新发布的求助

Process optimization for coaxial extrusion-based bioprinting: A comprehensive analysis of material behavior, structural precision, and cell viability 9分钟前
Safety and Feasibility of Yttrium-90 Radioembolization for Cirrhosis-Induced Splenomegaly and Thrombocytopenia: Results from an Investigational Device Exemption Study 15分钟前
Targeted Yttrium-90 Radioembolization of Metastatic Disease in the Spleen 15分钟前
Cancer mRNA vaccines: clinical application progress and challenges 1小时前
RNA interference with zilebesiran for mild to moderate hypertension: the KARDIA-1 randomized clinical trial 2小时前
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy 2小时前
Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions 2小时前
Zilebesiran: A novel RNA interference therapeutic for hypertension 2小时前
Add-on treatment with zilebesiran for inadequately controlled hypertension: the KARDIA-2 randomized clinical trial 2小时前
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease 2小时前
4-Ethoxyphenyltellurium Tribromide 2小时前
Injury and therapy in a human spinal cord organoid 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com